Men watch the stocks ticker displayed outside the Bombay Stock Exchange in Mumbai, India. (Photographer: Prashanth Vishwanathan/Bloomberg News)

Stocks To Watch: Coal India, HCL Tech, Jet Airways, Sun Pharma, Tata Steel

Asian stocks tumbled at the open on Tuesday, with Japanese benchmarks sliding more than 3 percent at one point, following a tech-led slump on Wall Street overnight thanks to a deteriorating outlook for iPhone sales.

Key indexes slid from Tokyo and Seoul to Sydney, and futures in Hong Kong pointed to a significant drop. The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, fell 0.5 percent to 10,447 as of 7:30 a.m.

Short on time? Well, then listen to this podcast for a quick summary of All You Need To Know before the opening bell.

Here Are The Stocks To Watch Out For In Today’s Trade.

  • Aurobindo Pharma entered into an agreement to purchase Research and Development assets from Australia based Advent Pharma, which deals in complex specialty generics. The total investment for this acquisition is pegged at $12.5 million.
  • HCL Technologies announced partnership with NetBrain Technologies to offer network visibility and network automation capabilities for enterprise IT teams.
  • NBCC received order for construction of Ayurveda Institute in Goa for Rs 260 crore. The company also reported that it had secured a total business of Rs 1,854 crores for the month of October.
  • Piramal Enterprises said it was considering raising capital via issue of non-convertible debentures on Nov. 15.
  • ATA Motors: Global wholesales for October up 6 percent at 1,09,597 units on a year on year basis. Commercial Vehicles global wholesales rose by 19 percent to 44,380 units and passenger vehicles sales declined by 2 percent to 65,217 units.
  • Lupin announced the launch of Atovane Oral Suspension USP launches in the U.S., after having received an approval from U.S. FDA earlier.
  • Shree Cements to add capacity in two plants located in Jharkhand and Odisha. The combined capacity addition will be 5.5 MTPA with a total investment of Rs 903 crore.
  • Cadila Healthcare clarified that on the news of “Kerala regulator finds three drugs of sub-standard quality” that Zipcet tablets were recalled by the company on June 29 and the batch was manufactured following current good manufacturing practices and released for sale only after batch meeting the pre-defined specifications, including dissolution.
  • TVS Motor launched Apache RTR 160 4V in Bangladesh.

Nifty Earnings To Watch

  • Tata Steel
  • Sun Pharma

Other Earnings To Watch

  • Mahanagar Gas
  • Abbott India
  • Allahabad Bank
  • Apollo Tyres
  • Ashok Leyland
  • AstraZeneca Pharma
  • Bombay Dyeing
  • CG Power and Industrial Solutions
  • Corporation Bank
  • Dalmia Bharat Sugar and Industries
  • Deepak Fertilizers and Petrochemicals
  • Dilip Buildcon
  • Engineers India
  • Glenmark Pharmaceuticals
  • Jindal Steel & Power
  • Kesoram Industries
  • NCC
  • Nesco
  • Novartis India

Earnings Reactions To Watch

Coal India (Q2, YoY)

  • Revenue up 22.3 percent to Rs 22,198.1 crore.
  • Net Profit at Rs 3,084.7 crore versus Rs 370.4 crore.
  • Ebitda at Rs 4,716 crore versus Rs 876.1 crore.
  • Ebitda Margin at 21.3 percent versus 4.8 percent.
  • Volume at 290.8 MT versus 269 MT.

Also read: Q2 Results: Coal India Profit Rises Over Eight Times, Meets Estimates

Eicher Motors (Q2, YoY)

  • Revenue up 11.1 percent at Rs 2,408.2 crore.
  • Net profit up 5.9 percent at Rs 548.8 crore.
  • Ebitda up 6.9 percent at Rs 729.4 crore.
  • Margin at 30.3 percent versus 31.5 percent.

Also read: Q2 Results: Eicher Motors’ Profit Misses Estimates

Jet Airways (Q2, YoY)

  • Revenue up 9.5 percent to Rs 6,161 crore.
  • Ebitdar loss at Rs 346 crore versus Ebitdar profit at Rs 837 crore.
  • Net loss at Rs 1,297 crore versus net profit at Rs 50 crore.
  • Revenue includes one-off item of Rs 111 crore.

Also read: Jet Airways' Liabilities Surge After Third Consecutive Loss

Aurobindo Pharma (Q2, YoY)

  • Revenue up 7.1 percent at Rs 4751.4 crore.
  • Net profit down 21.7 percent at Rs 611.4 crore.
  • Ebitda down 8.2 percent at Rs 1026 crore.
  • Margin at 21.6 percent versus 25.2 percent.
  • Exceptional loss of Rs 26.8 crore in the current quarter.
  • Forex loss of Rs 39.7 crore in current quarter.

Godrej Industries (Q2, YoY)

  • Revenue up 14.8 percent at Rs 2624 crore.
  • Net profit up 72.1 percent at Rs 135.6 crore.
  • Ebitda down 14.3 percent at Rs 135.8 crore.
  • Margin at 5.2 percent versus 6.9 percent.
  • Cost of property development at Rs 327.6 crore versus Rs 222.1 crore.

Bank of India (Q2, YoY)

  • Net interest income up 0.6 percent at Rs 2,926.8 crore.
  • Net loss at Rs 1,156.3 crore net profit at Rs 179.1 crore.
  • Provisions at Rs 2,827.6 crore versus Rs 2259.7 crore (QoQ)
  • GNPA at 16.36 percent versus 16.66 percent (QoQ)
  • NNPA at 7.64 percent versus 8.45 percent (QoQ)

UCO Bank (Q2. YoY)

  • Net interest income up 47.1 percent at Rs 964.6 crore.
  • Net loss at Rs 1,136.4 crore versus net loss at Rs 622.6 crore.
  • Provisions at Rs 1,410.9 crore versus Rs 2,038.3 crore. (QoQ)
  • GNPA at 25.37 percent versus 25.71 percent (QoQ)
  • NNPA at 11.97 percent versus 12.74 percent (QoQ)

JK Paper (Q2, YoY)

  • Revenue up 17.2 percent at Rs 785 crore.
  • Net profit up 93.6 percent at Rs 109.6 crore.
  • Ebitda up 48.2 percent at Rs 204.7 crore.
  • Margin at 26.1 percent versus 20.6 percent.

Nalco (Q2, YoY)

  • Revenue up 23.9 percent at Rs 3,040.9 crore.
  • Net profit up 117.4 percent at Rs 510 crore.
  • Ebitda up 153.7 percent at Rs 850.9 crore.
  • Margin at 28 percent versus 13.7 percent.

Oil India (Q2, QoQ)

  • Revenue up 10.4 percent at Rs 3,743.6 crore.
  • Net profit up 22.6 percent at Rs 862 crore.
  • Ebitda up 4.7 percent at Rs 1,474.7 crore.
  • Margin at 39.4 percent versus 41.5 percent.
  • Other income at Rs 287.8 crore versus Rs 126.8 crore.

Brigade Enterprises (Q2, YoY)

  • Revenue up 70.4 percent at Rs 825.9 crore.
  • Net profit up 67 percent at Rs 68.3 crore.
  • Ebitda up 63 percent at Rs 218.8 crore.
  • Margin at 26.5 percent versus 27.7 percent.

Apex Frozen Foods (Q2, YoY)

  • Revenue down 10.4 percent at Rs 255.5 crore.
  • Net profit down 10 percent at Rs 19.8 crore.
  • Ebitda down 19.4 percent at Rs 24.9 crore.
  • Margin at 9.7 percent versus 10.8 percent.

Jindal Saw (Q2, YoY)

  • Revenue up 76.9 percent at Rs 2,337.2 crore.
  • Net profit up 69.2 percent at Rs 101.7 crore.
  • Ebitda up 35.6 percent at Rs 299 crore.
  • Margin at 12.8 percent versus 16.7 percent.

Quick Heal Technologies (Q2, YoY)

  • Revenue up 4.2 percent at Rs 108.9 crore.
  • Net profit down 4 percent at Rs 37.7 crore.
  • Ebitda flat at Rs 60.3 crore.
  • Margin at 55.4 percent versus 57.6 percent.
  • Exceptional Loss of Rs 5 crore this quarter.

Jain Irrigation Systems (Q2, YoY)

  • Revenue up 20 percent at Rs 1,895 crore.
  • Net profit up 99 percent at Rs 21.2 crore.
  • Ebitda up 23 percent at Rs 215 crore.
  • Margin at 11.4 percent versus 11.1 percent.
  • Rise in profits from associate companies aided bottomline.

Hathway Cable (Q2, YoY)

  • Revenue flat at Rs 130.6 crore.
  • Net loss of Rs 5.9 crore versus net profit of Rs 14 crore.
  • Ebitda flat at Rs 53.8 crore.
  • Margins at 41.2 percent versus 41.1 percent.
  • Higher foreign exchange loss and interest cost impacted bottomline.

Bulk Deals

  • Usha Martin: Societe Generale acquired 18.9 lakh shares (0.67%) at Rs 44.88 each.

Trading Tweaks

  • Sakuma Exports record date for stock split from Rs 10 to Re 1.
  • Arfin India ex-date for 1:5 bonus issue.
  • SPS International and Tijaria Polypipes to move into ASM Framework.
  • Orient Press price band revised to 10 percent.
  • NALCO buyback window opens till Nov. 28.

Who’s Meeting Whom

  • KEC International to meet Macquarie Capital Securities and ICICI Securities from Nov. 13-15
  • Dr Lal PathLabs to meet Jackson Square Partners on Nov. 13.
  • Majesco to meet Sixteenth Street Capital (Singapore) on Nov. 13.

Insider Trading

  • Greaves Cotton promoter Karun Carpets acquired 43,000 shares from Nov. 6-11.
  • Meghmani Organics promoter and director Anandbhai Patel acquired 50,000 shares from Nov. 5-6.
  • MEP Infra Developers promoter Anuya Mhasikar acquired 1.75 lakh shares between Nov. 5-6.
  • S Chand promoter Neerja Jhunjhunwala acquired 6.5 lakh shares on Nov. 12.

Money Market Update

  • Rupee closed at 72.90/$ on Monday versus 72.5/$ on Friday.

F&O Cues

  • Nifty November futures closed trading at 10,504, premium of 21 points.
  • Nifty November open interest up 2.3 percent; Nifty Bank November open interest down 14 percent.
  • Max open interest for November series at 10,700 call option, (Open interest at 31.1 lakh shares)
  • Max open interest for November series at 10,000 put option, (open interest at 48.1 lakh shares)

Stocks In F&O Ban

  • Adani Power

Put-Call Ratio

  • Nifty PCR at 1.51 from 1.60.
  • Nifty Bank PCR at 0.85 from 1.17.

On Eicher Motors

CLSA

  • Maintained ‘Buy’ with a price target of Rs 30,000
  • Slight miss in September quarter; margins dipped sequentially due to higher fixed costs on a lower volume base.
  • Several demand headwinds in recent months, but some silver lining.
  • Royal Enfield growth slowdown hurting, but we retain faith in the franchise.

Macquarie

  • Maintained ‘Outperform’; cut price target to Rs 30,000 from Rs 37,000.
  • Earnings impacted by lower sales volumes.
  • Margins lower due to negative operating leverage and model launch expenses.
  • Mgmt. cut 2018-19 production by 25,000 units due to strike which is ongoing.

On Coal India

CLSA

  • Maintained ‘Buy’ with a price target of Rs 360.
  • September quarter’s operating income was ahead of estimates led by better-than-expected realisations.
  • Realisations higher due to large FSA price hike and rising e-auction prices.
  • Continue to like the stock given decent earnings growth outlook and attractive valuation.

Macquarie

  • Maintained ‘Outperform’ with a price target of Rs 335.
  • Strong prices drive in September quarter; adjusted operating income was inline.
  • FSA realisations have stabilised; upside from strong linkage auction ahead.
  • Risk reward attractive post divestment overhang; dividend yield could be higher.

On Aurobindo Pharma

Credit Suisse

  • Maintained ‘Outperform’ with a price target of Rs 840.
  • Strong beat in the U.S.; strategy of higher inventory delivering results.
  • Beat largely driven by volume gains in existing products which is likely to sustain.
  • Net debt reduction was lower than expected as inventory cycle continues to increase.

Citi

  • Maintained ‘Buy’ with a price target of Rs 1,030.
  • Reported strong September quarter results with beat on all fronts.
  • Beat appears to be mainly driven by strong traction in the U.S.
  • September quarter results validate that Auro is best placed; Q2 is just the start of an earnings ramp-up.

On Britannia

Macquarie

  • Maintained ‘Underperform’ with a price target of Rs 4210.
  • September quarter results were inline; domestic volume growth remains strong at 12 percent.
  • Widening direct distribution, increasing presence in rural market and weaker states drive volume.
  • Believe significant margin expansion going forward will be challenging.

BofAML

  • Maintained ‘Buy’ with a price target of Rs 7,090.
  • Strong September quarter with strong double-digit volume growth.
  • Expect Britannia to see solid volume growth over the medium term.
  • Margins to benefit from better operating leverage, improved product mix and cost-saving initiatives.

On Shree Cements

Macquarie

  • Maintained ‘Outperform’ with a price target of Rs 20,537.
  • September quarter was inline; strong volume partially offsets costs.
  • Prices hikes and strong volume growth to drive margin expansion from the second half of the current financial year.
  • Capacity growth to drive market-share gain in the current and the next financial year.

Morgan Stanley

  • Maintained ‘Underweight’ with a price target of Rs 18,736.
  • September quarter’s Ebitda above estimates driven by better than expected realisations.
  • Volume growth was strong at 16 percent, in line with estimate.
  • Net profit before tax down owing to lower other income.

More Calls

SBICAP on Jet Airways

  • Maintained ‘Hold’ with a price target of Rs 291.
  • Revenue supported by Rs 111 crore expected refund from a lessor.
  • International market see improvement, domestic continues to face pressure.
  • Payables shoot up on rising cash losses.

Nomura on Adani Ports

  • Maintained ‘Neutral’; cut price target to Rs 380 from Rs 431.
  • Strong delivery on volumes with significant improvements in cash generation.
  • Fairly valued due to rising interest rates impacting asset valuations.
  • Increase in pledged shares and financial weakness of group entities is an overhang.